Citation Tools
Abstracts accepted for publication
Cartilage, synovium and osteoimmunology
AB0060 Adalimumab is more effective than etanercept or abatacept at inhibiting tnf-enhanced human osteoclast development under in vitro conditions of chronic tnf exposure
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- AB0060 Adalimumab is more effective than etanercept or abatacept at inhibiting tnf-enhanced human osteoclast development under in vitro conditions of chronic tnf exposure